Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19
Saved in:
Main Authors: | Nina V. Vorobjeva (Author), Galina F. Sud'ina (Author), Boris V. Chernyak (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondria-targeted antioxidant SkQ1 inhibits leukotriene synthesis in human neutrophils
by: Galina F. Sud'ina, et al.
Published: (2022) -
Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
by: Boris V. Chernyak, et al.
Published: (2021) -
Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
by: Alexey V. Sokolov, et al.
Published: (2022) -
Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming
by: Ekaterina A. Golenkina, et al.
Published: (2022) -
Neutrophils Release Metalloproteinases during Adhesion in the Presence of Insulin, but Cathepsin G in the Presence of Glucagon
by: Natalia V. Fedorova, et al.
Published: (2018)